Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117553152 | 11755315 | 2 | F | 20141004 | 20141017 | 20151119 | 20160729 | EXP | US-MYLANLABS-2014M1008491 | MYLAN | 0.00 | Y | 0.00000 | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117553152 | 11755315 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 5 MG, QD | Y | U | 76418 | 5 | MG | TABLET | QD | |||||
| 117553152 | 11755315 | 2 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 UNK, UNK | Y | U | 76418 | 5 | MG | TABLET | QD | ||||
| 117553152 | 11755315 | 3 | SS | LINZESS | LINACLOTIDE | 1 | 145 ?G, QD | Y | U | 0 | 145 | UG | QD | ||||||
| 117553152 | 11755315 | 4 | SS | LINZESS | LINACLOTIDE | 1 | Oral | 145 UNK, UNK | Y | U | 0 | QD | |||||||
| 117553152 | 11755315 | 5 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | UNK | U | 0 | ||||||||||
| 117553152 | 11755315 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | U | 0 | ||||||||||
| 117553152 | 11755315 | 7 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | UNK | U | 0 | ||||||||||
| 117553152 | 11755315 | 8 | C | MULTIVITAMIN /00097801/ | VITAMINS | 1 | UNK | U | 0 | ||||||||||
| 117553152 | 11755315 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | U | 0 | ||||||||||
| 117553152 | 11755315 | 10 | C | CALCIUM | CALCIUM | 1 | UNK | U | 0 | ||||||||||
| 117553152 | 11755315 | 11 | C | AMOXI-CLAV | AMOXICILLINCLAVULANATE POTASSIUM | 1 | 87.5 MG, BID | U | 0 | 87.5 | MG | BID | |||||||
| 117553152 | 11755315 | 12 | C | PREDNISONE. | PREDNISONE | 1 | 10 MG, QD | U | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117553152 | 11755315 | 1 | Hypertension |
| 117553152 | 11755315 | 6 | Chronic obstructive pulmonary disease |
| 117553152 | 11755315 | 7 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117553152 | 11755315 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117553152 | 11755315 | Anxiety | |
| 117553152 | 11755315 | Balance disorder | |
| 117553152 | 11755315 | Blood pressure decreased | |
| 117553152 | 11755315 | Dizziness | |
| 117553152 | 11755315 | Dyspnoea | |
| 117553152 | 11755315 | Loss of control of legs | |
| 117553152 | 11755315 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117553152 | 11755315 | 1 | 20141004 | 0 | ||
| 117553152 | 11755315 | 2 | 20141006 | 20141007 | 0 | |
| 117553152 | 11755315 | 3 | 20141004 | 20141006 | 0 | |
| 117553152 | 11755315 | 4 | 20141008 | 0 |